Literature DB >> 32908832

Atypical Presenting Symptoms of Acute Onset Acquired Haemophilia with Eosinophilic Fasciitis.

Yuto Nakakubo1, Kazuyo Yamamoto2, Masaaki Fujita1,3.   

Abstract

Acquired haemophilia is a bleeding disorder caused by antibodies against coagulation factors. Some cases are associated with autoimmune diseases. However, no cases of acquired haemophilia with eosinophilic fasciitis have been previously reported. Herein we describe the case of a patient with eosinophilic fasciitis associated with acquired haemophilia. LEARNING POINTS: Eosinophilic fasciitis is one of the underlying diseases of acquired haemophilia.The underlying disease of acquired haemophilia should be investigated thoroughly and systematically to optimize therapeutic strategies.This is the first report of acquired haemophilia in association with eosinophilic fasciitis. © EFIM 2020.

Entities:  

Keywords:  Acquired haemophilia; eosinophilic fasciitis

Year:  2020        PMID: 32908832      PMCID: PMC7473686          DOI: 10.12890/2020_001722

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  13 in total

1.  A study of 65 patients with acquired hemophilia A in Taiwan.

Authors:  Shang-Yi Huang; Woei Tsay; Shyuann-Yuh Lin; Szu-Chun Hsu; Mei-Hwa Hung; Ming-Ching Shen
Journal:  J Formos Med Assoc       Date:  2013-03-29       Impact factor: 3.282

2.  Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.

Authors:  Masatoshi Jinnin; Toshiyuki Yamamoto; Yoshihide Asano; Osamu Ishikawa; Shinichi Sato; Kazuhiko Takehara; Minoru Hasegawa; Manabu Fujimoto; Hironobu Ihn
Journal:  J Dermatol       Date:  2017-12-13       Impact factor: 4.005

Review 3.  Acquired hemophilia A: Updated review of evidence and treatment guidance.

Authors:  Rebecca Kruse-Jarres; Christine L Kempton; Francesco Baudo; Peter W Collins; Paul Knoebl; Cindy A Leissinger; Andreas Tiede; Craig M Kessler
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

4.  Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.

Authors:  David Lebeaux; Camille Francès; Stéphane Barete; Bertrand Wechsler; Odile Dubourg; Jérôme Renoux; Thierry Maisonobe; Olivier Benveniste; Marc Gatfossé; Pierre Bourgeois; Zahir Amoura; Patrice Cacoub; Jean-Charles Piette; Damien Sène
Journal:  Rheumatology (Oxford)       Date:  2011-11-25       Impact factor: 7.580

5.  Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.

Authors:  Yoshiyuki Ogawa; Kunio Yanagisawa; Hideki Uchiumi; Takuma Ishizaki; Takeki Mitsui; Fumito Gouda; Masahiro Ieko; Akitada Ichinose; Yoshihisa Nojima; Hiroshi Handa
Journal:  Int J Hematol       Date:  2017-03-15       Impact factor: 2.490

Review 6.  Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.

Authors:  Carolyn Riester O'Connor
Journal:  Semin Arthritis Rheum       Date:  2014-12-04       Impact factor: 5.532

7.  Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  P Knoebl; P Marco; F Baudo; P Collins; A Huth-Kühne; L Nemes; F Pellegrini; L Tengborn; H Lévesque
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

Review 8.  Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.

Authors:  Lay Tay; Elizabeth Duncan; Deepak Singhal; Reem Al-Qunfoidi; Douglas Coghlan; Wilfred Jaksic; Ferenz Szabo; Simon McRae; John Lloyd
Journal:  Semin Thromb Hemost       Date:  2010-02-18       Impact factor: 4.180

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

10.  Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases.

Authors:  S Lakhanpal; W W Ginsburg; C J Michet; J A Doyle; S B Moore
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.